Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Biobanking Market
With a compound annual growth rate (CAGR) of XX% from 2024 to 2033, the worldwide biobanking market is projected to reach approximately US$ XX billion by 2033 from its estimated US$ XX billion in 2023. Precision medicine's explosive growth in biobanking highlights the technology's critical role in providing individualised healthcare. Biobanks have developed into sophisticated virtual repositories from traditional collections of tissues, blood, nucleic acids, samples of the microbiome, and stem cells. This development emphasises how important it is to have strong financial and infrastructure backing in order to continue their progress. Driven by the growing demand for biological data repositories that are comprehensive and easily available, as well as the growing need for precision medicine, the biobanking market is expected to experience considerable expansion due to the developing capabilities and uses of biobanking.
Market Overview Although the phrase "biobanking" is sometimes misused to refer to any collection of human biospecimens without taking into account the requisite ethical, legal, and process standardisation requirements, the biobanking market is expanding quickly. True biobanks are sizable collections of biospecimens connected to pertinent personal and health data, mainly for use in medical and health research. This data includes health records, family histories, lifestyle, and genetic information. As per the guidelines set forth by the International Organisation for Standardisation, biobanks are required to function as legal entities that oversee the procurement, preservation, testing, analysis, and distribution of biological materials and related data, along with managing the acquisition, storage, and related activities. The biobanking industry is expanding due to its extensive breadth and strict adherence to standards, which highlights its critical role in promoting personalised treatment and bolstering health research projects. • In October 2023, a philanthropic partnership unlocked £32 million to support the ongoing development of the UK Biobank. • In November 2023, Xybion completed the acquisition of Autoscribe Informatics, expanding its Laboratory Information Management System (LIMS) business.
Key Insights
• North America led the global market with the highest market share. • Europe region is estimated to expand the fastest CAGR in forecast period. • By product, the equipment segment has held the largest market share. • By services, the biobanking & repository service segment captured the biggest market share. • By biospecimen, the human tissues segment registered a maximum market share. • By biobank type, the physical biobanks segment generated highest market share. • By application, the drug discovery & clinical research segment captured the biggest market share.
Regional Stance As the market leader in biobanking, Europe has established its biobanks as essential intermediaries in modern biomedical research, acting as global hubs for the integration and dissemination of samples and the data that goes with them. One noteworthy project that works with research infrastructures to develop technologies and procedures that make microbiome samples and data more accessible is the MICROBE project, which is sponsored by the EU. One major area of interest is the microbiomes, which are made up of various microbes and their structural components, metabolites, signal molecules, and genetic components. To improve biomedical research, researchers, biobankers, industry stakeholders, and patients come together through BBMRI-ERIC, a European biobanking research infrastructure. By offering quality management services, support for ethics, law, and society, as well as a range of software solutions and online resources, BBMRI-ERIC strengthens Europe's leading position in the worldwide biobanking market. Over the course of the forecast period, the biobanking market is expected to grow at the fastest rate in the Asia Pacific region. After undergoing a quadrennial assessment by the Asia Pacific Accreditation Cooperation (APAC) in June 2022, A2LA reached a noteworthy milestone: it became the first accreditation authority in the world to obtain regional Mutual Recognition for ISO 20387 Biobanking under the MRA on October 2022. A key project in India that advances biobank science and encourages cooperation between scientists, biobankers, lawyers, industry stakeholders, and donors is the Biobank India Foundation (BBIF). Being a non-profit, BBIF raises awareness, encourages new developments in cryopreservation and biobanking, and offers solid advice to biobanks, both existing and startup. These changes highlight Asia Pacific's rapid expansion and rising stature in the world biobanking scene.
Report Highlights By Product Due to its significant market share, the equipment segment leads the worldwide biobanking industry. In close cooperation with molecular diagnostic departments, this section offers a variety of molecular analytic techniques and tools, including Sequenom Mass array, PCR, (digital) MLPA, Archer, HPV typing, NGS, and Nanostring. For the effective management and preservation of biological samples and data, certain instruments are necessary. The market for biobanking equipment is essential for sample collection, processing, cryopreservation, storage, and data management since biobanks, which are essential to medical research, provide samples that are connected to clinical data. Growing research in personalised medicine, the emergence of genomic research, and collaborative projects that call for standardised sample handling are driving the market's expansion. Biobanking equipment will keep enabling cutting-edge medical research as technology develops, guaranteeing its continued growth and significance. Source: https://www.slideshare.net/slideshow/biobanking-equipment-marketpdf/259939566 Over the course of the projection period, the Laboratory Information Management System (LIMS) is anticipated to have the greatest compound annual growth rate in the biobanking industry. By efficiently managing samples and related data, LIMS software helps labs to link instruments, automate processes, and improve information management. This improves efficiency by tracking data from sequencing runs across time and between experiments, resulting in faster, more accurate findings. Laboratory practices need to update their data management, tracking, and centralisation strategies in light of the extraordinary data quantities and sample throughput that modern genomics is producing, as well as the continuous developments in technology. In order to overcome these obstacles, LIMS adoption is essential, which has led to the product's notable rise in the biobanking market.
By Services According to estimates, the biobanking market is led by the biobanking and repository services category, which holds a substantial market share. Human biomaterials that are essential for research are collected, processed, distributed, cryogenically preserved, and information managed. These services create and manage biorepositories, which are essential domestic and worldwide resources for research on neurological disorders, ageing, and human diseases. The creation of independent biobanks, cryopreservation, fail-safe storage of DNA, cell lines, and other biomaterials, repository information management systems, and online catalogues with annotated samples are some of the company's key services. These services' comprehensiveness bolsters in-depth biomedical research and highlights their dominant position in the biobanking industry. Over the course of the forecast period, the lab processing sector of the biobanking market is anticipated to develop at the fastest rate. Analytical procedures are covered in this section, along with the tasks associated with actually testing specimens. For laboratory testing, having the right tools and procedures on hand is essential, as are well-thought-out equipment management strategies. These plans include ongoing calibration criteria for reagent testing and validation, as well as documentation of initial test validations and continuous validation during testing. Its fast expansion is fuelled by the strict and methodical approach to lab processing, which guarantees high-quality, dependable findings and emphasises its vital role in furthering biomedical research.
By Biospecimen Human tissues make up the largest and fastest-growing section of the biobanking market based on the kind of biospecimen. Tissue sample retention, preservation, and archiving offer a priceless resource for medical study. Research advancements depend heavily on biobanking, which is the systematic collection, documentation, preservation, and provision of body fluid or tissue samples. The use of human tissues in research projects has changed from being a luxury to a necessity, and it is now routine procedure in many biological research domains, not just toxicity. From early-stage discovery to clinical trials, biomarker-based research is now essential to the drug discovery process, allowing researchers to produce drugs with greater clinical success rates and reach ground-breaking outcomes. This change emphasises how crucial human tissue samples are becoming to advancing cutting-edge and productive biomedical research.
By Biobank Type Physical biobanks are the most common type of biobank on the market. These biobanks act as trustworthy centres for processing and storing samples from clinical trials and other sources, offering access to a sizable pool of superior human samples and related data. Physical biobanks are essential for guaranteeing repeatable research outcomes because they uphold strict guidelines for sample handling and storage. Their strong infrastructure and careful management techniques solidify their leadership in the biobanking industry and make them invaluable in the field of biomedical research. For the duration of the forecast period, virtual biobanks are anticipated to be the most promising category within the biobanking market. Virtual biobanks function as electronic databases where biological specimens and related data are digitally kept, in contrast to traditional biobanks that store specimens locally. Because they are virtual, they can bring disparate biospecimen collections—along with related genetic and background data—together into a single, readily navigable platform for researchers. Virtual biobanks facilitate immediate and effective access to a wide range of biospecimens that would normally require cooperation with many physical biobanks; this improves collaboration and streamlines research operations. This feature makes virtual biobanks essential to the advancement of biomedical research, providing the scale and flexibility required to satisfy the changing needs of contemporary research projects.
By Application Drug discovery and clinical research are the two most prominent application segments in the biobanking industry. Biobanks are essential for the advancement of preclinical research and the assistance of drug discovery initiatives. These repositories have vast collections of biological human samples, including DNA, blood, and tissues, giving scientists vital tools to improve patient outcomes and expand their understanding of disease causes. Human biological samples from biobanks are essential for evaluating the safety and effectiveness of drugs in preclinical research, lowering risks and hastening the creation of novel treatments. This application segment highlights the vital role that biobanks play in the pharmaceutical and clinical research industries, propelling advancements in innovation and healthcare. Market Dynamics
Driver Integration of Expertise and Collaborative Governance Fuel Biobanking Growth Because they guarantee strict adherence to ethical guidelines and quality standards, biobanks play a crucial role in supporting scientific research. The intricacy of biobanking activities requires strong finance, extensive organisational frameworks that span the scientific, technical, and administrative realms, and strong governance. It is essential that several stakeholders work together, especially pathology labs that prepare cancer tissue samples. Through careful treatment of specimens from the preanalytical to analytical phases, this collaboration guarantees that tumour cells and their surrounding microenvironment are the focus. Because these integrated methodologies enable enhanced tissue-based studies that are essential for increasing biomedical research and treatment development, they not only increase the dependability of research outputs but also propel the biobanking market's rise.
Restraints Challenges in Biobank Development and Sustainability
Creating biobanks requires managing the intricate processes involved in handling biospecimens while abiding by strict moral, legal, and societal norms pertaining to data security, informed permission, and privacy. While difficult, standardising procedures for quality control, storage, and sampling is essential. Another challenge is financial sustainability, since biobanks frequently have trouble obtaining enough money from a variety of sources, including grants from the government, commercial investors, and charitable contributions. The inability of many biobanks to recoup operating costs through fees limits their ability to expand within the market. To ensure the long-term viability and efficacy of biobanks in supporting scientific research, overcoming these challenges necessitates strong governance frameworks, tactical funding methods, and improved operating efficiencies.
Opportunities Next-Generation Biospecimens Drive Biobanking Innovation There is a growing demand in the biobanking industry for innovative products and processes that are suited to new research paradigms. These days, important cells like blood, bone marrow, foetal tissue, umbilical cord cells, and stem cell lines are among the biological samples kept for research purposes. For example, stem cell banking has several advantages, but in order to guarantee accurate results evaluation and the creation of secure, efficient treatments, strict standardisation and quality control must be implemented throughout the banking process. Growing patient-derived organoid (PDO) and patient-derived xenograft (PDX) cultures are broadening the use of living biobanks and providing an abundant resource for scientific research. The use of these next-generation biospecimens in therapeutic trials is growing, with funding for clinical research that is specifically allocated to meet these needs and incur certain expenses. This ever-changing landscape offers the biobanking industry tremendous potential to grow and innovate, propelling the field's progress in personalised medicine and hastening the creation of new therapies. • In June 2022, Mars Petcare launched an unprecedented scientific initiative aimed at enhancing the understanding of pet health and disease to enable personalized healthcare innovations for pets.
Recent Developments
• In January 2023, Crown Bioscience acquired Indivumed’s service business and supporting biobank. • In May 2024, IK Partners invested in BIOBank alongside management and historical shareholders Verto Growth and Capital Croissance. • In May 2022, BC Platforms announced partnerships with three Finnish biobanks to advance novel diagnostics and treatments.
Key Players in the Biobanking Market Thermo Fisher Scientific Inc. Tecan Trading AG QIAGEN Hamilton Company Brooks Life Sciences TTP Labtech VWR International, LLC. Promega Corporation Worthington Industries BD Merck KGaA Biokryo GmbH Cell&Co BioServices
Market Segmentation By Product Equipment Consumables Laboratory Information Systems By Service Biobanking and Repository Validation/Qualification Lab Processing Cold Chain Logistic Others By Biospecimen Type Human Tissues Stem Cells Organs Others By Biobank Physical Biobanks Virtual Biobanks By Application Drug Discovery and Clinical Research Therapeutics Clinical Diagnostics Others By Type of Biobank Population-based Biobanks Disease-oriented Biobanks By Ownership National/regional agency Non-Profit Organization Universities Private Organization By Storage Manual Storage Automated Storage
By Geography North America U.S. Canada Europe Germany France United Kingdom Rest of Europe Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific Latin America Brazil Rest of Latin America Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
Table of content 1. Introduction 1.1. Report Description 1.2. Research Methodology 1.2.1. Data Mining 1.2.2. Market Modeling and Forecasting 1.2.3. Data Validation 1.2.4. Industry Analysis
4. Biobanking Market by Product 4.1. Introduction 4.2. Biobanking Market Size and Growth Rate by Product (2021-2030) 4.3. Equipment 4.3.1. Equipment Market Size and Growth Rate (2019- 2030) 4.4. Consumables 4.4.1. Consumables Market Size and Growth Rate (2019- 2030) 4.5. Laboratory Information Systems 4.5.1. Laboratory Information Systems Market Size and Growth Rate (2021-2030)
5. Biobanking Market by Service 5.1. Introduction 5.2. Biobanking Market Size and Growth Rate by Service (2021-2030) 5.3. Biobanking and Repository 5.3.1. Biobanking and Repository Market Size and Growth Rate (2021-2030) 5.4. Validation/Qualification 5.4.1 Validation/Qualification Market Size and Growth Rate (2021-2030) 5.5. Lab Processing 5.5.1 Lab Processing Market Size and Growth Rate (2021-2030) 5.6. Cold Chain Logistic 5.6.1. Cold Chain Logistic Market Size and Growth Rate (2019- 2030) 5.7. Others 5.7.1. Others Market Size and Growth Rate (2021-2030)
6. Biobanking Market by Biospecimen Type 6.1. Introduction 6.2. Biobanking Market Size and Growth Rate by Biospecimen Type (2021-2030) 6.3. Human Tissues 6.3.1. Human Tissues Market Size and Growth Rate (2021-2030) 6.4. Stem Cells 6.4.1. Stem Cells Market Size and Growth Rate (2021-2030) 6.5. Organs 6.5.1. Organs Market Size and Growth Rate (2021-2030) 7. Biobanking Market by Biobank 7.1. Introduction 7.2. Biobanking Market Size and Growth Rate by Biobank (2021-2030) 7.3. Physical Biobanks 7.3.1. Physical Biobanks Market Size and Growth Rate (2021-2030) 7.5. Virtual Biobanks 7.5.1 Virtual Biobanks Market Size and Growth Rate (2021-2030) 7. Biobanking Market by Biobank 7.1. Introduction 7.2. Biobanking Market Size and Growth Rate by Biobank (2021-2030) 5.3. Physical Biobanks 7.3.1. Physical Biobanks Market Size and Growth Rate (2021-2030) 7.4. Virtual Biobanks 7.4.1 Virtual Biobanks Market Size and Growth Rate (2021-2030)
8. Company Profiles 8.1. Thermo Fisher Scientific Inc. 8.1.1. Business Overview 8.1.2. Service Portfolio 8.1.3. Strategic Developments 8.1.4. Financial Overview
8.2. Tecan Trading AG 8.2.1. Business Overview 8.2.2. Service Portfolio 8.2.3. Strategic Developments 8.2.4. Financial Overview
8.3. QIAGEN 8.3.1. Business Overview 8.3.2. Service Portfolio 8.3.3. Strategic Developments 8.3.4. Financial Overview
8.4. Hamilton Company 8.4.1. Business Overview 8.4.2. Service Portfolio 8.4.3. Strategic Developments 8.4.4. Financial Overview
8.5. Brooks Life Sciences 8.5.1. Business Overview 8.5.2. Service Portfolio 8.5.3. Strategic Developments 8.5.4. Financial Overview
8.6. TTP Labtech 8.6.1. Business Overview 8.6.2. Service Portfolio 8.6.3. Strategic Developments 8.6.4. Financial Overview
8.7. VWR International, LLC. 8.7.1. Business Overview 8.7.2. Service Portfolio 8.7.3. Strategic Developments 8.7.4. Financial Overview
8.8. Promega Corporation 8.8.1. Business Overview 8.8.2. Service Portfolio 8.8.3. Strategic Developments 8.8.4. Financial Overview
8.9. Worthington Industries 8.9.1. Business Overview 8.9.2. Service Portfolio 8.9.3. Strategic Developments 8.9.4. Financial Overview
8.8. BD 8.8.1. Business Overview 8.8.2. Service Portfolio 8.8.3. Strategic Developments 8.8.4. Financial Overview
8.11. Merck KGaA 8.11.1. Business Overview 8.11.2. Service Portfolio 8.11.3. Strategic Developments 8.11.4. Financial Overview
8.12. Biokryo GmbH 8.12.1. Business Overview 8.12.2. Service Portfolio 8.12.3. Strategic Developments 8.12.4. Financial Overview
8.13. Cell&Co BioServices 8.13.1. Business Overview 8.13.2. Service Portfolio 8.13.3. Strategic Developments 8.13.4. Financial Overview
9. List of Tables and Figures Table Biobanking Market Size and Market Share by Product (2021-2023) Table Biobanking Market Size and Market Share by Product (2023-2030) Figure Equipment Market Size and Growth Rate (2021-2030) Figure Consumables Market Size and Growth Rate (2021-2030) Figure Laboratory Information Systems Market Size and Growth Rate (2021-2030)
Table Biobanking Market Size and Market Share by Service (2021-2023) Table Biobanking Market Size and Market Share by Service (2023-2030) Figure Biobanking and Repository Market Size and Growth Rate (2021-2030) Figure Validation/Qualification Market Size and Growth Rate (2021-2030) Figure Lab Processing Market Size and Growth Rate (2021-2030) Figure Cold Chain Logistic Market Size and Growth Rate (2021-2030) Figure Others Market Size and Growth Rate (2021-2030)
Table Biobanking Market Size and Market Share by Biospecimen Type (2021-2023) Table Biobanking Market Size and Market Share by Biospecimen Type (2023-2030) Figure Human Tissues Market Size and Growth Rate (2021-2030) Figure Stem Cells Market Size and Growth Rate (2021-2030) Figure Organs Market Size and Growth Rate (2021-2030) Table Biobanking Market Size and Market Share by Biobank (2021-2023) Table Biobanking Market Size and Market Share by Biobank (2023-2030) Figure Physical Biobanks Market Size and Growth Rate (2021-2030) Figure Physical Biobanks Market Size and Growth Rate (2021-2030) Figure Physical Biobanks Devices Market Size and Growth Rate (2021-2030) Figure Physical Biobanks Market Size and Growth Rate (2021-2030)
Table Biobanking Market by Regions (2021-2023) Table Biobanking Market by Regions (2023-2030) Figure North America Biobanking Market Size and Growth Rate (2021-2030) Table North America Biobanking Market by Type (2021-2023) Table North America Biobanking Market by Type (2023-2030) Table North America Biobanking by Application (2021-2023) Table North America Biobanking by Application (2023-2030) Table North America Biobanking by Country (2021-2023) Table North America Biobanking by Country (2023-2030) Figure United States Biobanking Market Size and Growth Rate (2021-2030) Table United States Biobanking Market by Type (2021-2023) Table United States Biobanking Market by Type (2023-2030) Table United States Biobanking by Application (2021-2023) Table United States Biobanking by Application (2023-2030) Figure Canada Biobanking Market Size and Growth Rate (2021-2030) Table Canada Biobanking Market by Type (2021-2023) Table Canada Biobanking Market by Type (2023-2030) Table Canada Biobanking by Application (2021-2023) Table Canada Biobanking by Application (2023-2030) Figure Europe Biobanking Market Size and Growth Rate (2021-2030) Table Europe Biobanking Market by Type (2021-2023) Table Europe Biobanking Market by Type (2023-2030) Table Europe Biobanking by Application (2021-2023) Table Europe Biobanking by Application (2023-2030) Table Europe Biobanking by Country (2021-2023) Table Europe Biobanking by Country (2023-2030) Figure Germany Biobanking Market Size and Growth Rate (2021-2030) Table Germany Biobanking Market by Type (2021-2023) Table Germany Biobanking Market by Type (2023-2030) Table Germany Biobanking by Application (2021-2023) Table Germany Biobanking by Application (2023-2030) Figure France Biobanking Market Size and Growth Rate (2021-2030) Table France Biobanking Market by Type (2021-2023) Table France Biobanking Market by Type (2023-2030) Table France Biobanking by Application (2021-2023) Table France Biobanking by Application (2023-2030) Figure UK Biobanking Market Size and Growth Rate (2021-2030) Table UK Biobanking Market by Type (2021-2023) Table UK Biobanking Market by Type (2023-2030) Table UK Biobanking by Application (2021-2023) Table UK Biobanking by Application (2023-2030) Figure Russia Biobanking Market Size and Growth Rate (2021-2030) Table Russia Biobanking Market by Type (2021-2023) Table Russia Biobanking Market by Type (2023-2030) Table Russia Biobanking by Application (2021-2023) Table Russia Biobanking by Application (2023-2030) Figure Italy Biobanking Market Size and Growth Rate (2021-2030) Table Italy Biobanking Market by Type (2021-2023) Table Italy Biobanking Market by Type (2023-2030) Table Italy Biobanking by Application (2021-2023) Table Italy Biobanking by Application (2023-2030) Figure Rest of Europe Biobanking Market Size and Growth Rate (2021-2030) Table Rest of Europe Biobanking Market by Type (2021-2023) Table Rest of Europe Biobanking Market by Type (2023-2030) Table Rest of Europe Biobanking by Application (2021-2023) Table Rest of Europe Biobanking by Application (2023-2030) Figure Asia-Pacific Biobanking Market Size and Growth Rate (2021-2030) Table Asia-Pacific Biobanking Market by Type (2021-2023) Table Asia-Pacific Biobanking Market by Type (2023-2030) Table Asia-Pacific Biobanking by Application (2021-2023) Table Asia-Pacific Biobanking by Application (2023-2030) Table Asia-Pacific Biobanking by Country (2021-2023) Table Asia-Pacific Biobanking by Country (2023-2030) Figure China Biobanking Market Size and Growth Rate (2021-2030) Table China Biobanking Market by Type (2021-2023) Table China Biobanking Market by Type (2023-2030) Table China Biobanking by Application (2021-2023) Table China Biobanking by Application (2023-2030) Figure Japan Biobanking Market Size and Growth Rate (2021-2030) Table Japan Biobanking Market by Type (2021-2023) Table Japan Biobanking Market by Type (2023-2030) Table Japan Biobanking by Application (2021-2023) Table Japan Biobanking by Application (2023-2030) Figure Korea Biobanking Market Size and Growth Rate (2021-2030) Table Korea Biobanking Market by Type (2021-2023) Table Korea Biobanking Market by Type (2023-2030) Table Korea Biobanking by Application (2021-2023) Table Korea Biobanking by Application (2023-2030) Figure India Biobanking Market Size and Growth Rate (2021-2030) Table India Biobanking Market by Type (2021-2023) Table India Biobanking Market by Type (2023-2030) Table India Biobanking by Application (2021-2023) Table India Biobanking by Application (2023-2030) Figure Southeast Asia Biobanking Market Size and Growth Rate (2021-2030) Table Southeast Asia Biobanking Market by Type (2021-2023) Table Southeast Asia Biobanking Market by Type (2023-2030) Table Southeast Asia Biobanking by Application (2021-2023) Table Southeast Asia Biobanking by Application (2023-2030) Figure Rest of Asia-Pacific Biobanking Market Size and Growth Rate (2021-2030) Table Rest of Asia-Pacific Biobanking Market by Type (2021-2023) Table Rest of Asia-Pacific Biobanking Market by Type (2023-2030) Table Rest of Asia-Pacific Biobanking by Application (2021-2023) Table Rest of Asia-Pacific Biobanking by Application (2023-2030) Figure South America Biobanking Market Size and Growth Rate (2021-2030) Table South America Biobanking Market by Type (2021-2023) Table South America Biobanking Market by Type (2023-2030) Table South America Biobanking by Application (2021-2023) Table South America Biobanking by Application (2023-2030) Table South America Biobanking by Country (2021-2023) Table South America Biobanking by Country (2023-2030) Figure Brazil Biobanking Market Size and Growth Rate (2021-2030) Table Brazil Biobanking Market by Type (2021-2023) Table Brazil Biobanking Market by Type (2023-2030) Table Brazil Biobanking by Application (2021-2023) Table Brazil Biobanking by Application (2023-2030) Figure Mexico Biobanking Market Size and Growth Rate (2021-2030) Table Mexico Biobanking Market by Type (2021-2023) Table Mexico Biobanking Market by Type (2023-2030) Table Mexico Biobanking by Application (2021-2023) Table Mexico Biobanking by Application (2023-2030) Figure Columbia Biobanking Market Size and Growth Rate (2021-2030) Table Columbia Biobanking Market by Type (2021-2023) Table Columbia Biobanking Market by Type (2023-2030) Table Columbia Biobanking by Application (2021-2023) Table Columbia Biobanking by Application (2023-2030) Figure Rest of South America Biobanking Market Size and Growth Rate (2021-2030) Table Rest of South America Biobanking Market by Type (2021-2023) Table Rest of South America Biobanking Market by Type (2023-2030) Table Rest of South America Biobanking by Application (2021-2023) Table Rest of South America Biobanking by Application (2023-2030) Figure Middle East and Africa Biobanking Market Size and Growth Rate (2021-2030) Table Middle East and Africa Biobanking Market by Type (2021-2023) Table Middle East and Africa Biobanking Market by Type (2023-2030) Table Middle East and Africa Biobanking by Application (2021-2023) Table Middle East and Africa Biobanking by Country (2021-2023) Table Middle East and Africa Biobanking by Country (2023-2030) Figure Saudi Arabia Biobanking Market Size and Growth Rate (2021-2030) Table Saudi Arabia Biobanking Market by Type (2021-2023) Table Saudi Arabia Biobanking Market by Type (2023-2030) Table Saudi Arabia Biobanking by Application (2021-2023) Table Saudi Arabia Biobanking by Application (2023-2030) Figure United Arab Emirates Biobanking Market Size and Growth Rate (2021-2030) Table United Arab Emirates Biobanking Market by Type (2021-2023) Table United Arab Emirates Biobanking Market by Type (2023-2030) Table United Arab Emirates Biobanking by Application (2021-2023) Table United Arab Emirates Biobanking by Application (2023-2030) Figure South Africa Biobanking Market Size and Growth Rate (2021-2030) Table South Africa Biobanking Market by Type (2021-2023) Table South Africa Biobanking Market by Type (2023-2030) Table South Africa Biobanking by Application (2021-2023) Table South Africa Biobanking by Application (2023-2030) Figure Rest of Middle East and Africa Biobanking Market Size and Growth Rate (2021-2030) Table Rest of Middle East and Africa Biobanking Market by Type (2021-2023) Table Rest of Middle East and Africa Biobanking Market by Type (2023-2030) Table Rest of Middle East and Africa Biobanking by Application (2021-2023) Table Rest of Middle East and Africa Biobanking by Application (2023-2030)
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Biologics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Biologics Market for the past year and forecasts for the next six years. Global Biologics Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Biologics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Biologics Market from different application industries in different regions.
Market Segmentation By Product Equipment Consumables Laboratory Information Systems By Service Biobanking and Repository Validation/Qualification Lab Processing Cold Chain Logistic Others By Biospecimen Type Human Tissues Stem Cells Organs
